Paradigm Biocapital Advisors LP - 20 Mar 2025 SCHEDULE 13G Report for LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
LENZ
Shares outstanding
27,304,462 shares
Disclosed Ownership
1,419,832 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
27 Mar 2025, 16:21:15 UTC
Date of event
20 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 5.2% 1,419,832 1,419,832 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 5.2% 1,419,832 1,419,832 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 5.2% 1,419,832 1,419,832 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.6% 1,254,521 1,254,521 0 /s/ David K. Kim David K. Kim / Authorized Signatory